{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:52:34Z","timestamp":1792515154381,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-024-05018-0","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T09:02:38Z","timestamp":1724490158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence and associated factors of lipodystrophy in type 1 diabetic children and adolescents at Ayder Comprehensive Specialized Hospital, Tigray, Ethiopia"],"prefix":"10.1186","volume":"24","author":[{"given":"Tsehaye","family":"Alemseged","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdikarin Ahmed","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraha Gebreegziabher","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikaden Berhe","family":"Hadgu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Mustefa","family":"Mohammedamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"key":"5018_CR1","unstructured":"Atlas IDFD. 2019. Disponibil: https:\/\/diabetesatlas.org\/upload\/resources\/material\/20200302_133351_IDFATLAS9e-final-web. pdf (2020)."},{"key":"5018_CR2","unstructured":"Mohammed SF, Kedir MS, Maru TT. Lipohypertrophy - The Neglected Area of Concern in the much Talked about Diabetes. 2017;(June 2015)."},{"key":"5018_CR3","doi-asserted-by":"crossref","unstructured":"Singha A, Bhattacharjee R, Dalal BS, Biswas D, Choudhuri S, Chowdhury S, Zhang N, Zhao X, Wang F, He Y. H. Prevalence of lipohypertrophy in insulin-treated diabetes patients: A systematic review and meta-analysis. 2018;9(3).","DOI":"10.1111\/jdi.12742"},{"issue":"10","key":"5018_CR4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00128071-200304100-00001","volume":"4","author":"T Richardson","year":"2003","unstructured":"Richardson T, Kerr D. Skin-related complications of insulin therapy. Am J Clin Dermatol. 2003;4(10):661\u20137.","journal-title":"Am J Clin Dermatol"},{"key":"5018_CR5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/diacare.25.3.634","volume":"25","author":"O Kordonouri","year":"2002","unstructured":"Kordonouri O, Lauterborn R, Deiss D. Lipohypertrophy in young patients with type 1 diabetes. Diabetes Care. 2002;25:634. https:\/\/doi.org\/10.2337\/diacare.25.3.634.","journal-title":"Diabetes Care"},{"issue":"9","key":"5018_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.mayocp.2016.06.010","volume":"91","author":"AH Frid","year":"2016","unstructured":"Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231\u201355.","journal-title":"Mayo Clin Proc"},{"key":"5018_CR7","unstructured":"Specialized C. Glycemic control and its associated factors among diabetes mellitus patients\u2019 glycemic control and its associated factors among diabetes mellitus patients at Ayder comprehensive specialized hospital. Mekelle-Ethiopia. 2018.1467716."},{"key":"5018_CR8","doi-asserted-by":"crossref","unstructured":"Bishu KG, Jenkins C, Yebyo HG, Atsbha M, Wubayehu T. Diabetes in Ethiopia: a systematic review of prevalence, risk factors, complications, and cost. 2019;15(July):100132.","DOI":"10.1016\/j.obmed.2019.100132"},{"key":"5018_CR9","doi-asserted-by":"crossref","unstructured":"Ajlouni A, Abujbara M, Batieha A, Ajlouni K. Prevalence of Lipohypertrophy and Associated Risk factors in insulin-treated patients with type 2. Diabetes Mellitus. 2015;13(2).","DOI":"10.5812\/ijem.20776"},{"key":"5018_CR10","doi-asserted-by":"crossref","unstructured":"Aljaber AN, Sales I, Almigbal TH, Wajid S, Batais MA. The prevalence of lipohypertrophy and its associated factors among Saudi patients with type 2 diabetes mellitus. 2020;15(3):224\u201331.","DOI":"10.1016\/j.jtumed.2020.03.006"},{"key":"5018_CR11","unstructured":"Hospital S, Ababa A. Insulin Induced Lipohypertrophy and Glycemic Control among Children and Adolescents with Diabetes in Tikur Anbesa Afewerki Gebremeskel (B. Pharm) A Thesis Submitted to The Department of Pharmacology and Clinical Pharmacy, School of Pharmacy in Partial. 2017."},{"key":"5018_CR12","doi-asserted-by":"crossref","unstructured":"Barola A, Tiwari P, Bhansali A, Grover S, Dayal D. Insulin-Related Lipohypertrophy: Lipogenic Action or Tissue Trauma? 2018;9(October):1\u20138.","DOI":"10.3389\/fendo.2018.00638"},{"key":"5018_CR13","doi-asserted-by":"crossref","unstructured":"Tsadik AG, Atey TM, Nedi T, Fantahun B, Feyissa M. Effect of Insulin-Induced Lipodystrophy on Glycemic Control among Children and Adolescents with Diabetes in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. 2018;2018.","DOI":"10.1155\/2018\/4910962"},{"key":"5018_CR14","doi-asserted-by":"crossref","unstructured":"Gentile S, Strollo F, Ceriello A. Lipodystrophy and associated risk factors in insulin-treated people with diabetes, International Journal of Endocrinology and Metabolism, vol. 14, no. 2, article e33997, 2016.","DOI":"10.5812\/ijem.33997"},{"key":"5018_CR15","doi-asserted-by":"crossref","unstructured":"Alemayehu E, Id G, Kassie A, Id N. Glycemic control among diabetic patients in Ethiopia: a systematic review and meta-analysis. 2019;1\u201314.","DOI":"10.1371\/journal.pone.0221790"},{"key":"5018_CR16","doi-asserted-by":"crossref","unstructured":"Blanco M, Hern\u00e1ndez MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. 2013.05.006.","DOI":"10.1016\/j.diabet.2013.05.006"},{"issue":"4","key":"5018_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.14341\/DM9549","volume":"21","author":"VV Klimontov","year":"2018","unstructured":"Klimontov VV, Lazarev MM, Makhotin AA, Letyagin AJ, Anisimova LA, Bulumbaeva DM, Koroleva EA, Lykov AP. Insulin-induced lipohypertrophy: clinical and ultrasound characteristics. Diabetes Mellitus. 2018;21(4):255\u201363.","journal-title":"Diabetes Mellitus"},{"key":"5018_CR18","unstructured":"Cunningham MT, Mckenna M. Lipohypertrophy in insulin-treated diabetes: prevalence and associated risk factors. 2013;17(9)."},{"key":"5018_CR19","unstructured":"F P r, de Villiers. MMed (Paed), FcPaed, FAcP P. Lipohypertrophy \u2013 a complication of insulin injections.Nov. 2006:5\u20136."},{"issue":"1","key":"5018_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/1756-0500-4-290","volume":"4","author":"MA Omar","year":"2011","unstructured":"Omar MA, El-kafoury AA, El-araby RI. Lipohypertrophy in children and adolescents with type 1 diabetes and the associated factors. BMC Res Notes [Internet]. 2011;4(1):290.","journal-title":"BMC Res Notes [Internet]"},{"key":"5018_CR21","doi-asserted-by":"crossref","unstructured":"Chowdhury TA, Escudier V. Poor glycaemic control caused by insulin-induced lipohypertrophy. 2003;327(August):383\u20134.","DOI":"10.1136\/bmj.327.7411.383"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05018-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-05018-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05018-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:07:08Z","timestamp":1724929628000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-05018-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5018"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-05018-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,24]]},"assertion":[{"value":"19 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mohammed Mustefa Mohammedamin is the corresponding author, and his email address is mmustefa6@gmail.com. Tsehaye Alemseged is the first author, not the corresponding author.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"<b>Ethics statement<\/b>","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical clearance was obtained from the Institutional Review Board (IRB) of the College of Health Sciences of Mekelle University with IRB number ERC 1720\/2020. Permission from Ayder Comprehensive Specialized Hospital clinical director offices and a support letter from the chief clinical director were obtained before the commencement of the study. All procedures performed in this study were conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Consent was obtained from all caregivers of children involved in the study after they were informed about the objective and purpose of the study. They were also informed about their right to refuse to participate in the study at any time.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"548"}}